Dr Reddy's Laboratories said on Saturday it had received an approval from the US Food and Drug Administration for lansoprazole delayed-release capsules.
The firm will be launching the capsules, a bioequivalent generic version of Prevacid Delayed Release Capsules, in the US market, it said in a statement to the Bombay Stock Market Exchange.
. We are the Best share market tips provider in India for Intraday trading of cash , Nifty future and Nifty Options.We give only sure shot tips so that you can trade with high volume .
No comments:
Post a Comment